All fields are required.
Rockwell Medical In The News
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century
Drugs | April 18, 2016
Ferric pyrophosphate citrate (Triferic®) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Nephrology Dialysis Transplantation | July 13, 2015
A Novel Approach to Giving Iron
Renal & Urology News | June 4, 2015
Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients.
Kidney International | May 14, 2015
Rockwell Medical’s innovative drug Triferic will impact iron deficiency therapy around the world.
Prosper Magazine | April 3, 2015
Kidney treatment breakthrough boosts Wixom firm.
The Detroit News | March 14, 2015
© 2019 Rockwell Medical